22157.jpg
Global Oncology Partnering Report 2021: Deal Trends, Players and Financials for 4700 Deals
July 21, 2021 04:48 ET | Research and Markets
Dublin, July 21, 2021 (GLOBE NEWSWIRE) -- The "Global Oncology Partnering 2015-2021: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. The Global...
22157.jpg
Global Oncology Partnering Directory 2020 - Access to Over 4,000 Oncology Deal Records
February 05, 2021 08:28 ET | Research and Markets
Dublin, Feb. 05, 2021 (GLOBE NEWSWIRE) -- The "Global Oncology Partnering 2015-2020: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. The Global...
22157.jpg
Global Cancer Pain Pipeline Review, H2 2020 Report - Therapeutics Assessment of 36 Companies & Respective Drug Profiles
December 23, 2020 08:43 ET | Research and Markets
Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "Cancer Pain - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. Cancer Pain - Pipeline Review, H2 2020,...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Therapeutics Releases Positive Results of Phase 1B Trial of Resiniferatoxin (RTX) Epidural in Cancer Patients with Reported Intractable Pain
September 22, 2020 14:30 ET | Sorrento Therapeutics, Inc.
Seventeen subjects with advanced cancer pain received epidural RTX (0.4 to 25 mcg).No dose limiting toxicities were reported.A majority of patients reported meaningful pain reduction of 30% or more...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Therapeutics Presents Interim Positive Results of Phase 1b Resiniferatoxin (RTX) in Cancer Pain Trial
February 27, 2020 15:30 ET | Sorrento Therapeutics, Inc.
Fourteen subjects with advanced cancer pain received epidural RTX (04 to 15 ug)Most common treatment-related adverse event was transient post-procedure related painThree subjects at the higher doses...
Transparency Market Research
Pain Management Therapeutics Market to Reach US$83.0 Billion by 2024; Transparency Market Research
September 28, 2016 09:08 ET | Transparency Market Research
Albany - New York, Sept. 28, 2016 (GLOBE NEWSWIRE) -- With generic medicines accounting for a more than two-thirds of the global pain management therapeutics market, several small- and...